The clinical implications of medulloblastoma subgroups

被引：0

作者：

Paul A. Northcott

Andrey Korshunov

Stefan M. Pfister

Michael D. Taylor

机构：

[1] German Cancer Research Center (DKFZ),Division Molecular Genetics

[2] Clinical Cooperation Unit,undefined

[3] Neuropathology,undefined

[4] German Cancer Research Center (DKFZ),undefined

[5] The Arthur & Sonia Labatt Brain Tumor Research Centre,undefined

[6] Hospital for Sick Children,undefined

来源：

Nature Reviews Neurology | 2012年 / 8卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Medulloblastoma, once thought to represent a single disease entity, is now recognized to comprise distinct subgroups that can be identified using histological, genetic and transcriptomic approaches. Northcott et al. present the evidence for the four recently defined subgroups of medulloblastoma, and highlight how stratification of tumours into these subgroups could have important clinical implications for patient prognosis, treatment and care.

引用

页码：340 / 351

页数：11

共 50 条

[1] The clinical implications of medulloblastoma subgroups
Northcott, Paul A.
Korshunov, Andrey
Pfister, Stefan M.
Taylor, Michael D.
NATURE REVIEWS NEUROLOGY, 2012, 8 (06) : 340 - 351
[2] Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery
Schneider, Christian
Ramaswamy, Vijay
Kulkarni, Abhaya V.
Rutka, James T.
Remke, Marc
Tabori, Uri
Hawkins, Cynthia
Bouffet, Eric
Taylor, Michael D.
JOURNAL OF NEUROSURGERY-PEDIATRICS, 2015, 15 (03) : 236 - 242
[3] MEDULLOBLASTOMA - THE IDENTIFICATION OF PROGNOSTIC SUBGROUPS AND IMPLICATIONS FOR MULTIMODALITY MANAGEMENT
KOPELSON, G
LINGGOOD, RM
KLEINMAN, GM
CANCER, 1983, 51 (02) : 312 - 319
[4] MEDULLOBLASTOMA - CLINICAL SUBGROUPS DEFINED BY PATHOLOGICAL AND MOLECULAR ANALYSIS
Ellison, D.
NEURO-ONCOLOGY, 2010, 12 : 1 - 1
[5] Refining medulloblastoma subgroups
Juhnke, Bjoern-Ole
Mynarek, Martin
Rutkowski, Stefan
LANCET ONCOLOGY, 2017, 18 (07): : 847 - 848
[6] Molecular Subgroups In Medulloblastoma
Ellison, David
Dalton, James
Brat, Dan
Perry, Arie
Yong, William
Kocak, Mehmet
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2011, 70 (06): : 526 - 526
[7] Molecular subgroups of medulloblastoma
Northcott, Paul A.
Dubuc, Adrian M.
Pfister, Stefan
Taylor, Michael D.
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (07) : 871 - 884
[8] Comparison of Clinical and Molecular Wnt and SHH Subgroups in Medulloblastoma Tumor Cases
Kaya, Ismail Seckin
Aksoy, Secil
Mutlu, Melis
Tekin, Cagla
Taskapilioglu, Mevlut Ozgur
Tunca, Berrin
Civan, Muhammet Nafi
Ocak, Pinar Eser
Kocaeli, Hasan
Bekar, Ahmet
Egeli, Unal
Cecener, Gulsah
Tolunay, Sahsine
TURKISH NEUROSURGERY, 2021, 31 (04) : 554 - 565
[9] Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
Ramaswamy, Vijay
Remke, Marc
Et, Eric Bouff
Faria, Claudia C.
Perreault, Sebastien
Cho, Yoon-Jae
Shih, David J.
Luu, Betty
Dubuc, Adrian M.
Northcott, Paul A.
Schueller, Ulrich
Gururangan, Sridharan
McLendon, Roger
Bigner, Darell
Fouladi, Maryam
Ligon, Keith L.
Pomeroy, Scott L.
Dunn, Sandra
Triscott, Joanna
Jabado, Nada
Fontebasso, Adam
Jones, David T. W.
Kool, Marcel
Karajannis, Matthias A.
Gardner, Sharon L.
Zagzag, David
Nunes, Sofi A.
Pimentel, Jose
Mora, Jaume
Lipp, Eric
Walter, Andrew W.
Ryzhova, Marina
Zheludkova, Olga
Kumirova, Ella
Alshami, Jad
Croul, Sidney E.
Rutka, James T.
Hawkins, Cynthia
Tabori, Uri
Codispoti, Kari-Elise T.
Packer, Roger J.
Pfister, Stefan M.
Korshunov, Andrey
Taylor, Michael D.
LANCET ONCOLOGY, 2013, 14 (12): : 1200 - 1207
[10] Temporal evolution of medulloblastoma subgroups
Manoranjan, Branavan
Singh, Sheila K.
JOURNAL OF NEUROSURGERY-PEDIATRICS, 2015, 16 (03) : 349 - 350

← 1 2 3 4 5 →